‏إظهار الرسائل ذات التسميات Gynoveda. إظهار كافة الرسائل
‏إظهار الرسائل ذات التسميات Gynoveda. إظهار كافة الرسائل

Clinical Study Reveals An Ayurvedic Formulation’s Efficacy in Infertility Management; 85.23% Women Achieve Ovulation in 3 months

Clinical Study Reveals An Ayurvedic Formulation’s Efficacy in Infertility Management; 85.23% Women Achieve Ovulation in 3 months

Gynoveda’s Ayurvedic formulation becomes an evidence-based and safe ally for women in enabling gift of motherhood
  • “Clinical Evaluation of Ayurvedic Formulation Jeehv for its Ovulation Promoting Action in Females Suffering From Anovulation” by Dr. Aarati Patil, Dr. Divya C.S, and Dr. Gauri More published in the European Journal of Pharmaceutical and Medical Research
  • Gynoveda’s Ayurvedic supplement were found to be effective in assisting timely ovulation and thus can be useful in the management of infertility associated with gynecological disorders like PCOS, Irregular periods etc
  • The product was also found to be safe without causing any adverse effects
  • Gynoveda’s Ayurvedic supplement presented a success rate of 85.23% with 127 out of the 149 participants achieving ovulation in the span of 90 days at the latest
  • The clinical study is symbolic of Gynoveda’s vision of empowering women in India with an evidence-based medicinal system that delivers on-ground and tangible impact in women's healthcare by harnessing the power of Ayurveda
Gynoveda.com, an Ayurveda-backed women healthcare brand has taken a significant stride for women dealing with infertility issues. Its Ayurvedic supplement, recognized by European Journal of Pharmaceutical and Medical Research, was found to be effective in assisting timely ovulation and thus can be useful in the management of infertility associated with gynecological disorders like PCOS, Irregular periods etc. Conducted at Dhanwantari Ayurveda Centre, Pallakad, Kerala, India and amongst 149 participants (age group - 25-35 years) across India, the study reported 85.23% women achieving ovulation on time after consuming the Gynoveda’s Ayurvedic supplement (within 3 months). Moreover, no adverse drug reaction was observed offering women an opportunity to experience a safe motherhood.

Dr. Aarati Patil (MD, Ayurveda Gynaecology), Chief Doctor, Co-founder, and R&D Head, Gynoveda speaking about the breakthrough Ayurvedic formulation says, “With 15 years of experience in providing treatment to women grappling with severe gynecological disorders such as PCOS, fibroid, infertility, and endometriosis, I and my team are elated to have introduced a groundbreaking Ayurvedic supplement that possesses the potential to alleviate these disorders and conceive naturally.”

Gynoveda's Ayurvedic supplement has proven to be instrumental in assisting thousands of women in overcoming complications and achieving natural conception. This research paper is a testimony to Gynoveda’s mission to enable women to embrace the gift of motherhood.

Across the nation, women have enthusiastically shared their success stories, highlighting the efficacy of Gynoveda in their journey towards motherhood.

Gynoveda Co-founders R- L - Rachana, Vishal, Aarati
Gynoveda Co-founders (R- L) — Rachana, Vishal, Aarati

Sneha Chourasia from Madhya Pradesh says, "After seven years of marriage, I found success in conceiving with the help of Gynoveda. When I consulted doctors, they diagnosed me with PCOS, which made my journey to pregnancy more complicated. I tried different conventional methods to conceive, but they proved to be long and unsuccessful. As a last resort, I decided to give Gynoveda’s Ayurvedic supplement a try, incorporating it into my daily routine. To my delight, It worked its magic, enabling me to conceive naturally”

Minni Sharma from Lucknow says, “I spoke to gynaecologists and they told me about follicular study. They suggested inducing forceful ovulation injections; which was a very painful and an expensive process for me. I came across Gynoveda’s Ayurvedic supplement which is much more cost effective and efficient. Within just six months of incorporating it into my routine, I conceived naturally “

Abha Kumari from Patna says, "I can personally vouch for the remarkable benefits of Gynoveda’s Ayurvedic supplement when it comes to overcoming complex pregnancy challenges. Despite being diagnosed with fallopian tubal blockage, poor egg quality, and an ovarian cyst, I refused to give up. After trying various medical interventions, including the lengthy and fruitless process of IUI, I turned to Ayurveda supplement as my last hope. Incorporating it into my daily routine allowed me to conceive naturally “

Chetna Jain from Mumbai says, “Gynoveda’s 3x program which includes Diet, Medicine and Doctor support is an all rounded plan that helped me in my journey of a successful pregnancy. Before turning to Ayurveda, I opted for IVF and it did not give me the result I was hoping for. As a last resort, I incorporated Gynoveda’s Ayurvedic supplement in my daily routine and it helped me conceive naturally and give birth to a healthy baby”. 

Sunayani Bhowmik from Bangalore, whilst carrying her one and a half day old baby in her arms says, "Throughout my pursuit of a successful pregnancy, I explored the realms of allopathy and homeopathy for assistance. Unfortunately, these avenues failed to yield positive results. As a last recourse, I discovered Gynoveda's Ayurvedic supplement. To my delight, the initial evaluation following my utilization of Gynoveda’s supplement showcased a reduction in cystic growth. First thing I noticed after 2 months was that I had started having my regular period cycle and then I started taking PCOD pills religiously for two years."

Furthermore, the study also reported that 123 women(82.55%) had complaints of irregular menstrual cycle which was normalized in 98 women. No adverse drug reactions were observed and the study products were well tolerated.

Despite being informed that conceiving would be unattainable, women who had spent significant time and resources on modern medicine were able to fulfill their dream of motherhood through the Gynoveda’s breakthrough Ayurvedic supplement. Gynoveda proudly celebrates mothers and mothers-to-be with their continuous effort.

About Gynoveda

Gynoveda is the World’s first Ayurveda FemTech brand. It combines Ayurveda, Technology, Content & Community for women's healthcare, especially menstruation. Husband-wife duo Rachana & Vishal Gupta as founders of Gynoveda are on a mission to make Ayurveda as world’s first choice for women’s health from puberty to menopause. Gynoveda’s ayurvedic proprietary medicines with FDA approval have helped over 4 lakh women treat the root cause of disorders related to PCOS, irregular periods, infertility, pregnancy, skin, hair & general wellness. The company has delivered over 2 lakh orders across 20,000 pincodes in 58 major cities.

The company raised $10 million in March 2023 in Series A funding led by India Alternatives Fund. Since then its e-commerce platform Gynoveda.com is growing rapidly at 25% month-on-month and it's on track to cross ₹100 crores ARR in the current financial year. Gynoveda founders along with a team of doctors & scientists invented the world’s first Period Test, a gynecology bot that uses artificial intelligence (AI) to self-diagnose her reproductive health by answering a few questions on her mobile in just 2 minutes and getting results instantly.

Ayurveda-backed Women's Healthcare Startup Gynoveda Raises $10 Mn in Series A Funding Led by India Alternatives Fund

Ayurveda-backed Women's Healthcare Startup Gynoveda Raises $10 Mn in Series A Funding Led by India Alternatives Fund

Ayurveda-enabled curative solutions from puberty to menopause for 1 Million women of India

Round also saw participation from Wipro Enterprises, RPG Ventures, Dharampal Satyapal Ltd, and Alteria Capital amongst others. Existing investor Fireside Ventures, who had earlier invested $1 million as seed capital in Oct 2019, also participated in this round.

Gynoveda, an Ayurveda-backed women’s healthcare startup, has raised $10M in Series A funding led by India Alternatives Fund. The round also saw participation from reputed family offices and institutions including Wipro Enterprises, RPG Ventures, Dharampal Satyapal Ltd, and Alteria Capital. Existing investor Fireside Ventures, India’s leading early-stage venture capital fund, which had earlier invested $1 million as seed capital in Oct 2019, also participated in this round showcasing its continued belief in Gynoveda’s vision.

Gynoveda, founded in 2019 by the husband-wife duo - Rachana & Vishal Gupta and Dr. Aarati Patil aims to democratise Ayurveda-enabled, curative self-care solutions for gynaecological and lifestyle-related disorders women face from puberty to menopause.

With the help of this funding, the company aims to raise awareness about the importance of menstrual health on a grassroot level, making Ayurveda the first choice for women’s healthcare. Hence, the funds will be deployed to double down on strengthening R&D, formulating new ayurvedic offerings, onboarding talent, expanding distribution channels and increasing brand awareness. Currently, empowering women via D2C channels like the website, and e-commerce marketplaces, Gynoveda plans to step into the offline domain in the near future to reach women across the breadth and depth of India.

In a statement, the company Founder & CEO, Vishal Gupta, said that “Gynoveda has so far improved the health of 3 lakh women residing in 20,000 pincodes of India. This led to the company tripling its revenue year-on-year between FY20 and FY23 to reach ₹100 crores annual revenue run rate within 3 years of its inception. Gynoveda is on a mission to change the lives of 1 million women, which is still a fraction of the billion women worldwide that need this unique ayurvedic solution."

Shivani Bhasin Sachdeva, Founder, Managing Director, and CEO of the India Alternatives Private Equity Fund, said, “This investment fits perfectly with our investment themes of Women & Health. Today, over 40% of online shoppers are women, up from 10% a few years ago. Women’s health globally is an underserved market. We are proud to back a company that uses an age-old science like Ayurveda in a new format to provide solutions for this large addressable market."

Vinay Singh, Partner, Fireside Ventures, said, “Gynoveda’s disruptive vision combined with research-backed solutions is enabling it to bring tangible change in the lives of women. We are very impressed with how Vishal, Rachana & Dr. Aarati are building a robust healthcare stack for menstrual & reproductive health. We are glad to be a partner in their journey to completely transform women's healthcare ecosystem, ground up”

The Offering and Success

Gynoveda aims to revolutionise the $9.6 billion global women's healthcare industry by being the first player to introduce Ayurveda as a solution to solve complex gynaecological disorders. Gynoveda’s ayurvedic proprietary medicines certified by FDA & NABL, help treat the root cause of more than 20+ period disorders including PCOS, Infertility, irregular periods, vaginal health and much more. Where modern medicines offer only temporary relief, Ayurveda promises safe solutions to experience hassle-free periods lifelong.

The company has tripled its gross revenue year-on-year between FY20 and FY23 to reach INR 100 crores annual revenue run rate within 3 years of its inception. The google rating of 4.8 further reflects the growing customer love and trust by over 3 lakh women spread across 20,000 pincodes in India.

Past Funding & Team

In their Seed round, Gynoveda had raised a $1 million amount led by Fireside Ventures. In 2022, Bollywood actor Tapsee Pannu joined the brand’s mission as a brand ambassador.

Founded by Vishal & Rachana Gupta in 2019, who were later joined by Dr. Aarati Patil {M.D Obstetrics & Gynecology (Ayu)} the brand aims to transform the way gynaecological disorders are treated. Currently a team of 50+ members strong, it combines ayurveda, technology, content, and community for women’s healthcare.

About Gynoveda

Gynoveda is the World’s first Ayurveda FemTech brand. It combines Ayurveda, Technology, Content & Community for women's healthcare, primarily for menstrual & reproductive health.

Husband-wife duo Rachana & Vishal Gupta as founders of Gynoveda are on a mission to make Ayurveda as world’s first choice for women’s health from puberty to menopause. Gynoveda’s ayurvedic proprietary medicines with FDA approval have helped over 3 lakh women treat the root cause of disorders related to PCOS, irregular periods, infertility, vaginal health & overall welnness. The company has delivered over 4 lakh orders across 20,000 pincodes in more than 50 major cities.

The company raised $1 million in November 2019 from early-stage investment firm, Fireside Ventures. Since then its e-commerce platform Gynoveda.com is growing rapidly at 25% month-on-month and it's on track to cross ₹100 crores ARR in the current financial year.

Gynoveda founders along with a team of doctors & scientists invented the world’s first Period Test, a gynaecology bot that uses artificial intelligence (AI) to enable women self-diagnose her reproductive health by answering a few questions on her mobile in just 2 minutes and getting results instantly.

Market Reports

Market Report & Surveys
IndianWeb2.com © all rights reserved